<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35993441</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1552-5279</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</Title><ISOAbbreviation>Alzheimers Dement</ISOAbbreviation></Journal><ArticleTitle>CRISPR/Cas9 screen in human iPSC-derived cortical neurons identifies NEK6 as a novel disease modifier of C9orf72 poly(PR) toxicity.</ArticleTitle><Pagination><StartPage>1245</StartPage><EndPage>1259</EndPage><MedlinePgn>1245-1259</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/alz.12760</ELocationID><Abstract><AbstractText Label="INTRODUCTION">The most common genetic cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are hexanucleotide repeats in chromosome 9 open reading frame 72 (C9orf72). These repeats produce dipeptide repeat proteins with poly(PR) being the most toxic one.</AbstractText><AbstractText Label="METHODS">We performed a kinome-wide CRISPR/Cas9 knock-out screen in human induced pluripotent stem cell (iPSC) -derived cortical neurons to identify modifiers of poly(PR) toxicity, and validated the role of candidate modifiers using in vitro, in vivo, and ex-vivo studies.</AbstractText><AbstractText Label="RESULTS">Knock-down of NIMA-related kinase 6 (NEK6) prevented neuronal toxicity caused by poly(PR). Knock-down of nek6 also ameliorated the poly(PR)-induced axonopathy in zebrafish and NEK6 was aberrantly expressed in C9orf72 patients. Suppression of NEK6 expression and NEK6 activity inhibition rescued axonal transport defects in cortical neurons from C9orf72 patient iPSCs, at least partially by reversing p53-related DNA damage.</AbstractText><AbstractText Label="DISCUSSION">We identified NEK6, which regulates poly(PR)-mediated p53-related DNA damage, as a novel therapeutic target for C9orf72 FTD/ALS.</AbstractText><CopyrightInformation>&#xa9; 2022 The Authors. Alzheimer's &amp; Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Wenting</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-3585-7728</Identifier><AffiliationInfo><Affiliation>Stem Cell Institute, Department of Devolpment and Regeneration, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Laboratory of Neurobiology, KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Leuven, Belgium and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Haibo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of DNA Repair Research, Department of Neurosurgery, Center for Neuroregeneration, Houston Methodist Research Institute, Houston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience Research at Neurological Surgery, Weill Medical College, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar Tharkeshwar</LastName><ForeName>Arun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Laboratory of Neurobiology, KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Leuven, Belgium and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Couthouis</LastName><ForeName>Julien</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Genetics, Stanford University School of Medicine, Stanford, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Braems</LastName><ForeName>Elke</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Laboratory of Neurobiology, KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Leuven, Belgium and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masrori</LastName><ForeName>Pegah</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Laboratory of Neurobiology, KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Leuven, Belgium and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Schoor</LastName><ForeName>Evelien</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Laboratory of Neurobiology, KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Leuven, Belgium and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Neuropathology, Department of Imaging and Pathology, KU Leuven, and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Yannan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Stem Cell Institute, Department of Devolpment and Regeneration, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahuja</LastName><ForeName>Karan</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Stem Cell Institute, Department of Devolpment and Regeneration, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moisse</LastName><ForeName>Matthieu</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Laboratory of Neurobiology, KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Leuven, Belgium and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jacquemyn</LastName><ForeName>Maarten</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Furtado Madeiro da Costa</LastName><ForeName>Rodrigo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Stem Cell Institute, Department of Devolpment and Regeneration, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gajjar</LastName><ForeName>Madhavsai</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Stem Cell Institute, Department of Devolpment and Regeneration, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Balusu</LastName><ForeName>Sriram</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Leuven, Belgium and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tricot</LastName><ForeName>Tine</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Stem Cell Institute, Department of Devolpment and Regeneration, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fumagalli</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Laboratory of Neurobiology, KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Leuven, Belgium and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hersmus</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Laboratory of Neurobiology, KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Leuven, Belgium and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Janky</LastName><ForeName>Rekin's</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>VIB Nucleomics Core, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Impens</LastName><ForeName>Francis</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>VIB-UGent Center for Medical Biotechnology, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB Proteomics Core, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vanden Berghe</LastName><ForeName>Pieter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Translational Research Centre for Gastrointestinal Disorders (TARGID), KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Ritchie</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Neural Science and Medicine, Board of Governors Regenerative Medicine Institute, Departments of Biomedical Sciences and Neurology, Cedars-Sinai Medical Center, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thal</LastName><ForeName>Dietmar Rudolf</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Laboratory of Neuropathology, Department of Imaging and Pathology, KU Leuven, and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vandenberghe</LastName><ForeName>Rik</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KU Leuven-Laboratory for Cognitive Neurology, Department of Neurosciences, Leuven Brain Institute, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hegde</LastName><ForeName>Muralidhar L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Division of DNA Repair Research, Department of Neurosurgery, Center for Neuroregeneration, Houston Methodist Research Institute, Houston, Texas, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience Research at Neurological Surgery, Weill Medical College, New York, New York, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chandran</LastName><ForeName>Siddharthan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>UK-Dementia Research Institute at University College London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Strooper</LastName><ForeName>Bart</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Leuven, Belgium and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>UK-Dementia Research Institute at University College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Daelemans</LastName><ForeName>Dirk</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Damme</LastName><ForeName>Philip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Laboratory of Neurobiology, KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Leuven, Belgium and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University Hospitals Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Den Bosch</LastName><ForeName>Ludo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0104-4067</Identifier><AffiliationInfo><Affiliation>Department of Neurosciences, Experimental Neurology, Laboratory of Neurobiology, KU Leuven-University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>VIB, Center for Brain &amp; Disease Research, Leuven, Belgium and Leuven Brain Institute (LBI), Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verfaillie</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Stem Cell Institute, Department of Devolpment and Regeneration, KU Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NC/N001419/1</GrantID><Acronym>NC3RS_</Acronym><Agency>National Centre for the Replacement, Refinement and Reduction of Animals in Research</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 NS088645</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS112719</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 AG064266</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS094535</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 NS112719</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 AG064266</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MC_EX_MR/N50192X/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MR/N013255/1</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Alzheimers Dement</MedlineTA><NlmUniqueID>101231978</NlmUniqueID><ISSNLinking>1552-5260</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016159">Tumor Suppressor Protein p53</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C459456">NEK6 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D000072379">NIMA-Related Kinases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016159" MajorTopicYN="N">Tumor Suppressor Protein p53</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064113" MajorTopicYN="N">CRISPR-Cas Systems</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015027" MajorTopicYN="N">Zebrafish</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="N">DNA Repeat Expansion</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072379" MajorTopicYN="N">NIMA-Related Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">CRISPR/Cas9 screen</Keyword><Keyword MajorTopicYN="N">DNA damage</Keyword><Keyword MajorTopicYN="N">NEK6</Keyword><Keyword MajorTopicYN="N">PR toxicity</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia</Keyword><Keyword MajorTopicYN="N">human pluripotent stem cells</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">p53</Keyword></KeywordList><CoiStatement>CONFLICT OF INTERESTS. D.R.T. received speaker honorary or travel reimbursement from Novartis Pharma AG (Switzerland), UCB (Belgium), GE-Healthcare (UK), Biogen (USA), and collaborated with Novartis Pharma AG (Switzerland), Probiodrug (Germany), GE-Healthcare (UK), and Janssen Pharmaceutical Companies (Belgium). The other authors declare no competing interests. Author disclosures are available in the supporting information.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>22</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35993441</ArticleId><ArticleId IdType="mid">NIHMS1825305</ArticleId><ArticleId IdType="pmc">PMC9943798</ArticleId><ArticleId IdType="doi">10.1002/alz.12760</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27:1918&#x2013;1929. doi:10.1111/ene.14393</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14393</ArticleId><ArticleId IdType="pmc">PMC7540334</ArticleId><ArticleId IdType="pubmed">32526057</ArticleId></ArticleIdList></Reference><Reference><Citation>van Es MA, Hardiman O, Chio A, et al. Amyotrophic lateral sclerosis. Lancet. 2017;390(10107):2084&#x2013;2098. doi:10.1016/S0140-6736(17)31287-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Kirby J, Highley R, Shaw PJ. The spectrum of C9orf72-mediated neurodegeneration and amyotrophic lateral sclerosis. Neurotherapeutics. 2015;12(2):326&#x2013;339. doi:10.1007/s13311-015-0342-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0342-1</ArticleId><ArticleId IdType="pmc">PMC4404438</ArticleId><ArticleId IdType="pubmed">25731823</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon I, Xiang S, Kato M, et al. Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science. 2014;345(6201):1139&#x2013;1145. doi:10.1126/science.1254917</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1254917</ArticleId><ArticleId IdType="pmc">PMC4459787</ArticleId><ArticleId IdType="pubmed">25081482</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizielinska S, Gr&#xf6;nke S, Niccoli T, et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science. 2014;345:1192&#x2013;1194. doi:10.1126/science.1256800</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1256800</ArticleId><ArticleId IdType="pmc">PMC4944841</ArticleId><ArticleId IdType="pubmed">25103406</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen X, Tan W, Westergard T, et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron. 2014;84(6):1213&#x2013;1225. doi:10.1016/j.neuron.2014.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.010</ArticleId><ArticleId IdType="pmc">PMC4632245</ArticleId><ArticleId IdType="pubmed">25521377</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeynaems S, Bogaert E, Michiels E, et al. Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci Rep. 2016;6(1):20877. doi:10.1038/srep20877</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep20877</ArticleId><ArticleId IdType="pmc">PMC4751451</ArticleId><ArticleId IdType="pubmed">26869068</ArticleId></ArticleIdList></Reference><Reference><Citation>Swinnen B, Bento-Abreu A, Gendron TF, et al. A zebrafish model for C9orf72 ALS reveals RNA toxicity as a pathogenic mechanism. Acta Neuropathol. 2018;135(3):427&#x2013;443. doi:10.1007/s00401-017-1796-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1796-5</ArticleId><ArticleId IdType="pubmed">29302778</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli L, Young FL, Boeynaems S, et al. C9orf72 -derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility. Sci Adv. 2021;7:eabg3013. doi:10.1126/sciadv.abg3013</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abg3013</ArticleId><ArticleId IdType="pmc">PMC8034861</ArticleId><ArticleId IdType="pubmed">33837088</ArticleId></ArticleIdList></Reference><Reference><Citation>Burgess DJ. Shining a light on genetic screen strategies. Nat Rev Genet. 2018;19(1):6&#x2013;7. doi:10.1038/nrg.2017.99</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrg.2017.99</ArticleId><ArticleId IdType="pubmed">29129919</ArticleId></ArticleIdList></Reference><Reference><Citation>Kramer NJ, Haney MS, Morgens DW, et al. CRISPR&#x2013;Cas9 screens in human cells and primary neurons identify modifiers of C9ORF72 dipeptide-repeat-protein toxicity. Nat Genet. 2018;50(4):603&#x2013;612. doi:10.1038/s41588-018-0070-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0070-7</ArticleId><ArticleId IdType="pmc">PMC5893388</ArticleId><ArticleId IdType="pubmed">29507424</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W, Wang S, Zhang Z, et al. CRISPR-Cas9 screens identify the RNA helicase DDX3X as a repressor of C9ORF72 (GGGGCC)n repeat-associated Non-AUG translation. Neuron. 2019;72:1&#x2013;14. doi:10.1016/j.neuron.2019.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.09.003</ArticleId><ArticleId IdType="pmc">PMC6895427</ArticleId><ArticleId IdType="pubmed">31587919</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Vandoorne T, Steyaert J, Staats KA, Van Den Bosch L. The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications. Brain. 2020;143(6):1651&#x2013;1673. doi:10.1093/brain/awaa022</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa022</ArticleId><ArticleId IdType="pmc">PMC7296858</ArticleId><ArticleId IdType="pubmed">32206784</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson FM, Gray NS. Kinase inhibitors: the road ahead. Nat Rev Drug Discov. 2018;17(5):353&#x2013;377. doi:10.1038/nrd.2018.21</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd.2018.21</ArticleId><ArticleId IdType="pubmed">29545548</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanden Berghe P, Hennig GW, Smith TK. Characteristics of intermittent mitochondrial transport in guinea pig enteric nerve fibers. Am J Physiol Gastrointest Liver Physiol. 2004;286(4):G671&#x2013;G682. doi:10.1152/ajpgi.00283.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00283.2003</ArticleId><ArticleId IdType="pubmed">14592946</ArticleId></ArticleIdList></Reference><Reference><Citation>Debray S, Race V, Crabb&#xe9; V, et al. Frequency of C9Orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study. Neurobiol Aging. 2013;34(12):2890.e7&#x2013;2890.e12. doi:10.1016/j.neurobiolaging.2013.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.06.009</ArticleId><ArticleId IdType="pubmed">23870417</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordov&#xe1;s L, Boon R, Pistoni M, et al. Efficient recombinase-mediated cassette exchange in hPSCs to study the hepatocyte lineage reveals AAVS1 locus-mediated transgene inhibition. Stem Cell Reports. 2015;5(5):918&#x2013;931. doi:10.1016/j.stemcr.2015.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2015.09.004</ArticleId><ArticleId IdType="pmc">PMC4649136</ArticleId><ArticleId IdType="pubmed">26455413</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Kirwan P, Livesey FJ. Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nat Protoc. 2012;7(10):1836&#x2013;1846. doi:10.1038/nprot.2012.116</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2012.116</ArticleId><ArticleId IdType="pubmed">22976355</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Xu H, Xiao T, et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens. Genome Biol. 2014;15(12):554. doi:10.1186/s13059-014-0554-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0554-4</ArticleId><ArticleId IdType="pmc">PMC4290824</ArticleId><ArticleId IdType="pubmed">25476604</ArticleId></ArticleIdList></Reference><Reference><Citation>Freixo F, Manso Y, et al. NEK7 regulates dendrite morphogenesis in neurons via Eg5-dependent microtubule stabilization. Nat Commun. 2018;9:2330. doi:10.1038/s41467-018-04706-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-04706-7</ArticleId><ArticleId IdType="pmc">PMC5997995</ArticleId><ArticleId IdType="pubmed">29899413</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinojosa AJ, Deogracias R, Rico B. The microtubule regulator NEK7 coordinates the wiring of cortical parvalbumin interneurons. Cell Rep. 2018;24:1231&#x2013;1242. doi:10.1016/j.celrep.2018.06.115</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.06.115</ArticleId><ArticleId IdType="pmc">PMC6088228</ArticleId><ArticleId IdType="pubmed">30067978</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Meng J, Bi F, et al. NEK7 regulates NLRP3 inflammasome activation and neuroinflammation post-traumatic brain injury. Front Mol Neurosci. 2019;12:247. doi:10.3389/fnmol.2019.00202</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2019.00202</ArticleId><ArticleId IdType="pmc">PMC6804551</ArticleId><ArticleId IdType="pubmed">31660054</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry AM, O&#x2019;Regan L, Sabir SR, Bayliss R. Cell cycle regulation by the NEK family of protein kinases. J Cell Sci. 2012;125(Pt 19):4423&#x2013;4433. doi:10.1242/jcs.111195</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.111195</ArticleId><ArticleId IdType="pmc">PMC3500863</ArticleId><ArticleId IdType="pubmed">23132929</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow SA, Guttenplan KA, Clarke LE, et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541(7638):481&#x2013;487. doi:10.1038/nature21029</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A, Hunt CR, Chakraborty S, et al. Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice. Radiat Res. 2014;125:4423&#x2013;4433. doi:10.1667/RR13572.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1667/RR13572.1</ArticleId><ArticleId IdType="pmc">PMC4133096</ArticleId><ArticleId IdType="pubmed">24320053</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg MA, Konopka A, Soo KY, Ito D, Atkin JD. The DNA damage response (DDR) is induced by the C9orf72 repeat expansion in amyotrophic lateral sclerosis. Hum Mol Genet. 2017;26(15):2882&#x2013;2896. doi:10.1093/hmg/ddx170</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx170</ArticleId><ArticleId IdType="pubmed">28481984</ArticleId></ArticleIdList></Reference><Reference><Citation>Prudencio M, Belzil VV, Batra R, et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat Neurosci. 2015;18:1175&#x2013;1182. doi:10.1038/nn.4065</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4065</ArticleId><ArticleId IdType="pmc">PMC4830686</ArticleId><ArticleId IdType="pubmed">26192745</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Lin S, Staats KA, et al. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med. 2018;24(3):313&#x2013;325. doi:10.1038/nm.4490</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>De Donato M, Righino B, Filippetti F, et al. Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6. Sci Rep. 2018;8(1):16047. doi:10.1038/s41598-018-34471-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-34471-y</ArticleId><ArticleId IdType="pmc">PMC6207720</ArticleId><ArticleId IdType="pubmed">30375481</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Kooij B, Creixell P, van Vlimmeren A, et al. Comprehensive substrate specificity profiling of the human Nek kinome reveals unexpected signaling outputs. Elife. 2019;8:e44635. doi:10.7554/eLife.44635</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.44635</ArticleId><ArticleId IdType="pmc">PMC6570481</ArticleId><ArticleId IdType="pubmed">31124786</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandli M, Feige E, Chen A, Kilfin G, Motro B, Isolation and characterization of two evolutionarily conserved murine kinases (Nek6 and Nek7) related to the fungal mitotic regulator, NIMA. Genomics. 2000;68(2):187&#x2013;196. doi:10.1006/geno.2000.6293</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/geno.2000.6293</ArticleId><ArticleId IdType="pubmed">10964517</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Regan L, Fry AM. The Nek6 and Nek7 protein kinases are required for robust mitotic spindle formation and cytokinesis. Mol Cell Biol. 2009;29(14):3975&#x2013;3990. doi:10.1128/MCB.01867-08</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01867-08</ArticleId><ArticleId IdType="pmc">PMC2704745</ArticleId><ArticleId IdType="pubmed">19414596</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurell E, Beck K, Krupina K, et al. Phosphorylation of Nup98 by multiple kinases is crucial for NPC disassembly during mitotic entry. Cell. 2011;46:26&#x2013;32. doi:10.1016/j.cell.2011.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.01.012</ArticleId><ArticleId IdType="pubmed">21335236</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S, Cleveland DW, Disrupted nuclear import-export in neurodegeneration. Science. 2016;351:125&#x2013;126. doi:10.1126/science.aad9872</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aad9872</ArticleId><ArticleId IdType="pmc">PMC4842317</ArticleId><ArticleId IdType="pubmed">26744395</ArticleId></ArticleIdList></Reference><Reference><Citation>Raices M, D&#x2019;Angelo MA. Nuclear pore complexes and regulation of gene expression. Curr Opin Cell Biol. 2017;46:26&#x2013;32. doi:10.1016/j.ceb.2016.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceb.2016.12.006</ArticleId><ArticleId IdType="pmc">PMC5505778</ArticleId><ArticleId IdType="pubmed">28088069</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenna KP, van Doormaal PTC, Dekker AM, et al. NEK1 variants confer susceptibility to amyotrophic lateral sclerosis. Nat Genet. 2016;48(9):1037&#x2013;1042. doi:10.1038/ng.3626</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3626</ArticleId><ArticleId IdType="pmc">PMC5560030</ArticleId><ArticleId IdType="pubmed">27455347</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen HP, Van Mossevelde S, Dillen L, et al. NEK1 genetic variability in a Belgian cohort of ALS and ALS-FTD patients. Neurobiol Aging. 2018;61:255.e1&#x2013;255.e7. doi:10.1016/j.neurobiolaging.2017.08.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.08.021</ArticleId><ArticleId IdType="pubmed">28935222</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu S, Lei X, Liu F, et al. Mutation screening of NEK1 in Chinese ALS patients. Neurobiol Aging. 2018;71:267.e1&#x2013;267.e4. doi:10.1016/j.neurobiolaging.2018.06.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.06.022</ArticleId><ArticleId IdType="pubmed">30093141</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Lin H, Wang X, Zuo Q, Qin J, Zhang P. The NEK1 interactor, C21ORF2, is required for efficient DNA damage repair. Acta Biochim Biophys Sin (Shanghai). 2015;47(10):834&#x2013;841. doi:10.1093/abbs/gmv076</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abbs/gmv076</ArticleId><ArticleId IdType="pmc">PMC4581587</ArticleId><ArticleId IdType="pubmed">26290490</ArticleId></ArticleIdList></Reference><Reference><Citation>de Oliveira AP, Issayama LK, Pavan ICB, et al. Checking neks: overcoming a bottleneck in human diseases. Molecules. 2020;25:1178. doi:10.3390/molecules25081778</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25081778</ArticleId><ArticleId IdType="pmc">PMC7221840</ArticleId><ArticleId IdType="pubmed">32294979</ArticleId></ArticleIdList></Reference><Reference><Citation>Maor-Nof M, Shipony Z, Lopez-Gonzalez R, et al. p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). Cell. 2021;184(3):689&#x2013;708.e20. doi:10.1016/j.cell.2020.12.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.12.025</ArticleId><ArticleId IdType="pmc">PMC7886018</ArticleId><ArticleId IdType="pubmed">33482083</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker C, Herranz-Martin S, Karyka E, et al. C9orf72 expansion disrupts ATM-mediated chromosomal break repair. Nat Neurosci. 2017;20:1225&#x2013;1235. doi:10.1038/nn.4604</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4604</ArticleId><ArticleId IdType="pmc">PMC5578434</ArticleId><ArticleId IdType="pubmed">28714954</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M, Pal A, Goswami A, et al. Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat Commun. 2018;9(1):335. doi:10.1038/s41467-017-02299-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin M-J. Linking Nek6 to p53-induced senescence. Cell Cycle. 2011;10(1):23&#x2013;22. doi:10.4161/cc.10.1.14222</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.10.1.14222</ArticleId><ArticleId IdType="pubmed">21200148</ArticleId></ArticleIdList></Reference><Reference><Citation>Jee HJ, Kim HJ, Kim AJ, et al. The inhibition of Nek6 function sensitizes human cancer cells to premature senescence upon serum reduction or anticancer drug treatment. Cancer Lett. 2013;335:175&#x2013;182. doi:10.1016/j.canlet.2013.02.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.canlet.2013.02.012</ArticleId><ArticleId IdType="pubmed">23416273</ArticleId></ArticleIdList></Reference><Reference><Citation>Walton CC, Zhang W, Pati&#xf1;o-Parrado I, Barrio-Alonso E, Garrido JJ, Frade JM, Primary neurons can enter M-phase. Sci Rep. 2019;9:4594. doi:10.1038/s41598-019-40462-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-40462-4</ArticleId><ArticleId IdType="pmc">PMC6418114</ArticleId><ArticleId IdType="pubmed">30872646</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens J, Herdy JR, Traxler L, et al. Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer&#x2019;s patients. Cell Stem Cell. 2021;28:1533&#x2013;1548. doi:10.1016/j.stem.2021.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2021.04.004</ArticleId><ArticleId IdType="pmc">PMC8423435</ArticleId><ArticleId IdType="pubmed">33910058</ArticleId></ArticleIdList></Reference><Reference><Citation>Usluer S, Spreitzer E, Bourgeois B, Madl T. P53 transactivation domain mediates binding and phase separation with poly-pr/gr. Int J Mol Sci. 2021;22:11431. doi:10.3390/ijms222111431</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111431</ArticleId><ArticleId IdType="pmc">PMC8583712</ArticleId><ArticleId IdType="pubmed">34768862</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CW, Martinez-Yamout MA, Dyson HJ, Wright PE. Structure of the p53 transactivation domain in complex with the nuclear receptor coactivator binding domain of CREB binding protein. Biochemistry. 2010;49(46):9964&#x2013;9971. doi:10.1021/bi1012996</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi1012996</ArticleId><ArticleId IdType="pmc">PMC2982890</ArticleId><ArticleId IdType="pubmed">20961098</ArticleId></ArticleIdList></Reference><Reference><Citation>Krois AS, Ferreon JC, Martinez-Yamout MA, Dyson HJ, Wright PE. Recognition of the disordered p53 transactivation domain by the transcriptional adapter zinc finger domains of CREB-binding protein. Proc Natl Acad Sci. 2016;113(13):E1853&#x2013;E1862. doi:10.1073/pnas.1602487113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1602487113</ArticleId><ArticleId IdType="pmc">PMC4822595</ArticleId><ArticleId IdType="pubmed">26976603</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>